e-learning
resources
Amsterdam 2015
Monday, 28.09.2015
IPF: clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF)
Hwang In Kyoung (Seoul , Republic of Korea), In Kyoung Hwang, Seon Hye Kim, Myung Jae Park, Hong Mo Kang
Source:
International Congress 2015 – IPF: clinical aspects
Session:
IPF: clinical aspects
Session type:
Poster Discussion
Number:
2041
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hwang In Kyoung (Seoul , Republic of Korea), In Kyoung Hwang, Seon Hye Kim, Myung Jae Park, Hong Mo Kang. Clinical significance of falling oxygen saturation per walking distance (ΔSaO2/6MWD) during six minute walk test (6MWT) in idiopathic pulmonary fibrosis (IPF). Eur Respir J 2015; 46: Suppl. 59, 2041
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients
A modified staged treatment algorithm using the AeriSeal System
Static and dynamic lung volumes and their measurement
Related content which might interest you:
A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF
Source: International Congress 2015 – IPF: clinical aspects II
Year: 2015
6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID)
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012
Analysis of oxygen saturation (O2 sat.) During the six minutes walk distance (6MWD) test in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
The six minute walk test (6MWT) can predict O
2
flows required to prevent exercise induced O
2
desaturation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis
Year: 2010
The reliability and validity of the 4 metre gait speed (4MGS) in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
Year: 2016
Effect of continued pirfenidone treatment following a ≥ 15% decline in 6-minute walk distance (6MWD) in patients with idiopathic pulmonary fibrosis (IPF): Pooled analysis from 3 pivotal studies
Source: International Congress 2016 – New and old therapies for chronic lung diseases
Year: 2016
Combination of six-minute walk test (6MWT) and exhaled carbon monoxide (eCO) measurement in patients with exogenous allergic alveolitis (EAE) and idiopathic pulmonary fibrosis (IPF) – test of a new approach
Source: Eur Respir J 2007; 30: Suppl. 51, 580s
Year: 2007
Challenges in idiopathic pulmonary fibrosis trials: the point on end-points
Source: Eur Respir Rev 2011; 20: 195-200
Year: 2011
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 96-103
Year: 2005
The six minute walking test: Clinical predictors of survival in idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013
Echocardiographic findings in severe chronic obstructive pulmonary disease (COPD) patients who desaturate during 6-minute walking test (6MWT)
Source: Annual Congress 2011 - Clinical physiology for clinical problems
Year: 2011
Correlation of composite physiologic index with 6-minute walk test variables in patients with idiopathic interstitial pneumonias
Source: International Congress 2016 – Clinical exercise physiology in health and disease
Year: 2016
Relationship of cardiopulmonary exercise testing (CPET) and lung function in idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2007; 30: Suppl. 51, 120s
Year: 2007
Change in 6 minute walk distance (6MWD) following a familiarisation test and exercise training in patients with chronic obstructive pulmonary disease (COPD): influence of disability
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008
Sex differences in physiological progression of idiopathic pulmonary fibrosis
Source: Eur Respir J 2008; 31: 1183-1188
Year: 2008
Clinical predictors of pulmonary hypertension in sarcoidosis
Source: Eur Respir J 2008; 32: 296-302
Year: 2008
FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
Source: Eur Respir J, 55 (5) 1902151; 10.1183/13993003.02151-2019
Year: 2020
Change in 6-minute walk test can predict prognosis in idiopathic pulmonary fibrosis
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
What is the role of hypoxaemia, 6-minute walk test, diffusion capacity, pulmonary arterial hypertension in diffuse interstitial lung diseases?
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009
Resting DL
CO
predictis exercise lung gas exchange efficiency but not walking distance at 6‘WT in idiopathic pulmonary artery hypertension (IPAH)
Source: Eur Respir J 2005; 26: Suppl. 49, 106s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept